NA
BIO icon

NewEdge Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

NewEdge Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.7K Buy
91
+12
+15% +$3.4K ﹤0.01% 3277
2026
Q1 		$22K Sell
79
-13
-14% -$3.74K ﹤0.01% 3166
2025
Q4 		$27.9K Hold
92
– – ﹤0.01% 3150
2025
Q3 		$25.8K Sell
92
-2
-2% -$544 ﹤0.01% 3038
2025
Q2 		$22.7K Sell
94
-34
-27% -$8.04K ﹤0.01% 2912
2025
Q1 		$31.2K Sell
128
-34
-21% -$10.2K ﹤0.01% 2707
2024
Q4 		$53.2K Buy
162
+5
+3% +$1.7K ﹤0.01% 2506
2024
Q3 		$52.5K Sell
157
-49
-24% -$15.6K ﹤0.01% 2416
2024
Q2 		$56.3K Sell
206
-325
-61% -$94.5K ﹤0.01% 2304
2024
Q1 		$184K Sell
531
-155
-23% -$51K ﹤0.01% 1870
2023
Q4 		$222K Sell
686
-3
-0.4% -$940 ﹤0.01% 1670
2023
Q3 		$247K Sell
689
-2,396
-78% -$924K ﹤0.01% 1526
2023
Q2 		$1.17M Buy
3,085
+354
+13% +$144K 0.01% 795
2023
Q1 		$1.31M Buy
2,731
+191
+8% +$89.4K 0.02% 686
2022
Q4 		$73.3K Buy
+2,540
New +$1.03M ﹤0.01% 1571
2022
Q1 		– Sell
-272
Closed -$206K – 1199
2021
Q4 		$206K Sell
272
-1,341
-83% -$1M ﹤0.01% 1510
2021
Q3 		$1.2M Buy
+1,613
New +$1.21M 0.03% 460
2021
Q1 		– Sell
-1,054
Closed -$614K – 1034
2020
Q4 		$614K Buy
1,054
+167
+19% +$95.1K 0.02% 554
2020
Q3 		$457K Buy
+887
New +$449K 0.02% 605

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

NewEdge Advisors's BIO Position: Q2 2026 in Review

NewEdge Advisors increased its Bio-Rad Laboratories Class A (BIO) stake by 15% in Q2 2026, buying an estimated $3.4K and bringing the position to 91 shares worth $26.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3277.

NewEdge Advisors first reported a position in BIO in Q3 2020 and has held it in 19 quarters since. The position peaked at $1.31M in Q1 2023. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • NewEdge Advisors held 91 shares of Bio-Rad Laboratories Class A worth $26.7K as of Q2 2026.
  • NewEdge Advisors bought 12 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $3.4K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #3277 holding.
  • NewEdge Advisors first reported a position in Bio-Rad Laboratories Class A in Q3 2020 and has held it in 19 quarters since.
  • NewEdge Advisors's Bio-Rad Laboratories Class A position peaked at $1.31M in Q1 2023.
  • 398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.